18 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33778077 | Association of Matrix Metalloproteinase-2 mRNA Expression with Subtypes of Pediatric Cholesteatoma. | 2021 | 1 |
2 | 32314796 | Expression of CXCR4 and MMP-2 is associated with poor prognosis in patients with osteosarcoma. | 2020 Aug | 1 |
3 | 25259564 | Presence of matrix metalloproteinase-2 and tissue inhibitor matrix metalloproteinase-2 gene polymorphisms and immunohistochemical expressions in intracranial meningiomas. | 2014 Dec | 1 |
4 | 22553708 | Expression of MMP-2 and MMP-9 in retinoblastoma and their significance. | 2011 | 1 |
5 | 22820140 | Expression of matrix metalloproteinase-2 and its tissue inhibitor-2 in fetal and neoplastic thyroid tissue and their significance as diagnostic and prognostic markers in papillary carcinoma. | 2011-2012 | 1 |
6 | 18587209 | Expression of matrix metalloproteinases 2 and 9 in odontogenic myxoma in vivo and in vitro. | 2008 Jun | 1 |
7 | 18925697 | Immunohistochemically detected high expression of matrix metalloproteinase-2 as predictor of poor prognosis in Duke's B colon cancer. | 2008 Oct | 1 |
8 | 16309203 | Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma. | 2005 Nov-Dec | 1 |
9 | 14569466 | Increased expression of MMP-2 and MMP-9 in esophageal squamous cell carcinoma. | 2004 Jan | 1 |
10 | 15051038 | Expression of matrix metalloproteinases in patients with uterine smooth muscle tumors: an immunohistochemical analysis of MMP-1 and MMP-2 protein expression in leiomyoma, uterine smooth muscle tumor of uncertain malignant potential, and leiomyosarcoma. | 2004 Apr | 1 |
11 | 15571322 | Cellular protein and mRNA expression patterns of matrix metalloproteinases-2, -3 and -9 in human breast cancer: correlation with tumour growth. | 2004 Jun | 1 |
12 | 12602907 | Matrix metalloproteinase-2 (MMP-2) in T(1-2)N0 breast carcinoma. | 2003 Jan | 1 |
13 | 14624933 | Matrix metalloproteinase-2 immunoreactive protein as a prognostic marker in bladder cancer. | 2003 Nov | 1 |
14 | 12404291 | Immunohistochemical expression of vascular endothelial growth factor, matrix metalloproteinase 2, and matrix metalloproteinase 9 in cutaneous melanocytic lesions. | 2002 Nov 1 | 1 |
15 | 11245340 | Matrix metalloproteinase-2 (MMP-2) is associated with the risk for a relapse in postmenopausal patients with node-positive breast carcinoma treated with antiestrogen adjuvant therapy. | 2001 Jan | 1 |
16 | 11482578 | Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. | 2001 | 1 |
17 | 10718490 | MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinoma. | 1999 Dec | 1 |
18 | 9875140 | Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. | 1998 Sep | 1 |